B9928

Anti-Bone Morphogenetic Protein Receptor 2 antibody produced in goat

affinity isolated antibody, lyophilized powder

• Synonim(y): Anti-BMP R2
• Numer MDL: MFCD02095904
• Kod UNSPSC: 51111800

Właściwości

• pochodzenie biologiczne: goat
• białko sprzężone: unconjugated
• forma przeciwciała: affinity isolated antibody
• rodzaj przeciwciała: primary antibodies
• klon: polyclonal
• Formularz: lyophilized powder
• reaktywność gatunkowa: human
• metody: indirect ELISA: 0.5-1.0 μg/mL; western blot: 0.1-0.2 μg/mL
• numer dostępu UniProt: Q13873
• temp. przechowywania: −20°C
• informacje o genach: human ... BMPR2(659)

Opis

Opis ogólny

Bone morphogenetic proteins (BMPs) are the members of the TGF-β superfamily and are identified as the critical factors for formation of bone and cartilage, hematopoietic cell formation and mesoderm patterning. Apart from this BMPs have immune regulatory functions. The cellular effects of BMPs are mediated by a heteromeric complex composed of type I and type II receptors. Bone Morphogenetic Protein Receptor 2 (BMP R2) is a 70-80kD protein that belongs to serine/threonine kinases family. BMPs bind to BMP R2 and then recruits the transducing type I receptor which in turn activate the Smad protein signaling pathway. Anti-Bone Morphogenetic Protein Receptor 2 (BMP R2) antibody can be used in western blotting (working concentration:- 0.1-0.2 μg/mL). Goat anti-BMP R2 antibody reacts specifically with recombinant human BMP-R2. The antibody exhibits 10% (approx.) cross-reactivity with recombinant mouse BMP-RIB using reducing conditions and less than 1% cross-reactivity with recombinant mouse BMP-RIA and recombinant human BMP-RIA.

Specyficzność

By immunoblotting (reducing conditions), the antibody shows 10% cross-reactivity with recombinant mouse BMP RIB and <1% cross-reactivity with recombinant human BMP RIA and recombinant mouse BMP RIA.

Immunogen

recombinant human BMP R2 expressed in NSO cells.

Zastosowanie

Anti-Bone Morphogenetic Protein Receptor 2 (BMP R2) antibody may be used in indirect ELISA at a working antibody concentration of 0.5-1.0 μg/ml.

Postać fizyczna

Lyophilized from solution in phosphate buffered saline containing 5% trehalose.

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Ta strona może zawierać tekst przetłumaczony maszynowo.